A hashtag page of personal Trulicity posts, including one user who says insurance denied Ozempic because she was only prediabetic.
Recap by typeshit. Video by TikTok on TikTok.
A Facebook user criticizes telehealth marketing of tirzepatide and other GLP-1 services that targets new mothers, calling it predatory. One person's opinion.
Dr. Noc joined StarTalk to cover GLP-1 drugs, creatine, peptides and looksmaxxing. The full talk is out on YouTube and in podcast apps.
The obesity doctor says commenters once treated her early support for these medications as heresy. She adds that she saw their potential back in 2005.
A TikTok playlist collects GLP-1 updates from creator @stephaniemua1. There is no detail on what the videos cover beyond the playlist name.
Strive Specialties failed to revive its suit over GLP-1 competition. Novo still faces soft 2026 forecasts and an exploratory CagriSema analysis in women.
Reuters saw a Heineken presentation flagging GLP-1 drugs as a threat to beer sales, a rare admission from a major alcohol maker.
Loading…